With inflation trends mixed, central banks cautious and energy prices in focus, many investors are looking for a steadier source of returns than relying only on share price moves. That is where high quality dividend powerhouses come in. This Dividend Powerhouses (3%+ Yield) screener focuses on companies offering more than a 5% yield that is described as covered, growing and stable, which can be appealing when bond yields, growth signals and policy paths all look uncertain. In this article, you will see 3 of the strongest stocks from the screener and what stands out about each one.
Overview: CSL is a global biopharmaceutical group headquartered in Melbourne that develops and manufactures plasma derived therapies, vaccines and treatments for conditions such as immune deficiencies, bleeding disorders, iron deficiency and kidney disease through its CSL Behring, CSL Seqirus and CSL Vifor businesses.
Operations: CSL generates most of its revenue from CSL Behring at about US$10.9b, with CSL Vifor contributing roughly US$2.4b and CSL Seqirus around US$2.2b, and earns this across major markets including the United States at about US$7.3b and the Rest of World at roughly US$4.6b.
Market Cap: A$54.7b
CSL gives dividend focused investors exposure to an essential healthcare business, backed by a large plasma therapy franchise and global flu vaccine and kidney care operations that serve patients with limited treatment alternatives. The current story is not without issues, as recent one off losses, higher debt, margin pressure and a relatively new board all add risk, and the dividend is not well covered by earnings. At the same time, earnings are forecast to grow strongly, the company is running a sizeable buyback program and is working through a major cost reset. For investors willing to weigh those trade offs, CSL may be more interesting than its recent share price performance suggests.
CSL’s mix of covered income, recent one off hits and a major cost reset suggests the headline story may not match the underlying trajectory. It can be worth reviewing the analyst forecasts for CSL to see what might be quietly building
Overview: Accenture is a Dublin based professional services company that helps large organisations across sectors like finance, healthcare, public service and technology to design, build and run their IT systems, business processes and AI driven solutions.
Operations: Accenture generates most of its revenue from Products at about US$22.3b, followed by Health & Public Service at roughly US$14.9b, Financial Services at about US$13.8b, Communications, Media & Technology at around US$12.4b and Resources at roughly US$9.8b.
Market Cap: US$89.9b
Accenture may appeal to dividend investors who want both income and exposure to AI and digital transformation. The stock combines a 4.44% yield with current ROE around 23.7%, and trades on a P/E of 11.5x that is below peers and the broader US IT sector. Analysts currently forecast earnings growth of about 8.46% per year. However, recent earnings slipped 2% and revenue is expected to grow at a modest 4.8% per year, while a newer management team and heavy AI related restructuring introduce execution risk. For investors comfortable with those trade offs, Accenture’s mix of cash returns, large scale AI partnerships and discounted valuation may warrant a closer look.
Accenture’s 4.44% yield, strong ROE and lower P/E suggest that the market may be underrating its AI and digital engine. Before that gap closes, review the analyst forecasts for Accenture to see what expectations might be missing.
Overview: Securitas is a Stockholm headquartered security company that provides on site guarding, mobile patrols, remote video monitoring, electronic security and risk advisory services to corporate and institutional clients across North America, Europe, Ibero America and other regions.
Operations: Securitas generates most of its revenue from Securitas Europe at about SEK 66.9b and Securitas North America at roughly SEK 59.8b, with Securitas Ibero America contributing around SEK 15.0b and Other activities about SEK 9.5b.
Market Cap: SEK86.5b
Securitas could interest dividend focused investors looking for a security services company that is leaning into higher margin, technology driven contracts while still generating cash. Earnings have grown 13.3% a year over 5 years and net margins increased to 3.7%, supported by cost cutting, portfolio rationalization and a focus on tech and security solutions that lifted the adjusted operating margin to 7.6% in the first half of 2026. At the same time, high debt, an unstable dividend record and mixed recent growth, including weaker Technology & Solutions performance in the U.S., indicate ongoing risks. The stock also trades well below Simply Wall St’s cash flow value, which may appeal to investors who think the market is underpricing this shift.
Securitas is shifting toward higher margin, tech heavy security contracts while the market still prices it like a low growth guard business, so the analysis report for Securitas could be the missing piece that explains whether rising margins are masking one crucial fault line
The three dividend stocks covered here are only a starting point, as the full Dividend Powerhouses (3%+ Yield) screen surfaced 1,886 more companies with equally compelling income stories and business narratives, all gathered in the Dividend Powerhouses (3%+ Yield) screener. Identify and analyze the specific catalysts, balance sheet strength and dividend profiles that matter most to you so you can focus on the highest conviction ideas rather than sifting through the entire market yourself.
If CSL or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Markets move fast, and the best ideas rarely stay quiet for long. Scan fresh stock lists before momentum takes off, while it still matters, and get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com